DE69813555D1 - Gegen die fläche von cryptosporidium-oozysten gerichteten igg1-klasse antikörper - Google Patents

Gegen die fläche von cryptosporidium-oozysten gerichteten igg1-klasse antikörper

Info

Publication number
DE69813555D1
DE69813555D1 DE69813555T DE69813555T DE69813555D1 DE 69813555 D1 DE69813555 D1 DE 69813555D1 DE 69813555 T DE69813555 T DE 69813555T DE 69813555 T DE69813555 T DE 69813555T DE 69813555 D1 DE69813555 D1 DE 69813555D1
Authority
DE
Germany
Prior art keywords
oocyst
igg1
animal
cryptosporidium
antibodies reactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69813555T
Other languages
English (en)
Other versions
DE69813555T2 (de
Inventor
Graham Vesey
Christopher Weir
Leslie Williams
Basil Slade
Duncan Veal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Australian Water Technologies Pty Ltd
Access Macquarie Ltd
Original Assignee
Australian Water Technologies Pty Ltd
Macquarie Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO6962A external-priority patent/AUPO696297A0/en
Priority claimed from AUPO8242A external-priority patent/AUPO824297A0/en
Application filed by Australian Water Technologies Pty Ltd, Macquarie Research Ltd filed Critical Australian Water Technologies Pty Ltd
Publication of DE69813555D1 publication Critical patent/DE69813555D1/de
Application granted granted Critical
Publication of DE69813555T2 publication Critical patent/DE69813555T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69813555T 1997-05-19 1998-05-19 Gegen die fläche von cryptosporidium-oozysten gerichteten igg1-klasse antikörper Expired - Lifetime DE69813555T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPO6962A AUPO696297A0 (en) 1997-05-19 1997-05-19 Antibodies to cryptosporidium
AUPO696297 1997-05-19
AUPO824297 1997-07-25
AUPO8242A AUPO824297A0 (en) 1997-07-25 1997-07-25 Antibodies to cryptosporidium
PCT/AU1998/000368 WO1998052974A1 (en) 1997-05-19 1998-05-19 ANTIBODIES TO $i(CRYPTOSPORIDIUM)

Publications (2)

Publication Number Publication Date
DE69813555D1 true DE69813555D1 (de) 2003-05-22
DE69813555T2 DE69813555T2 (de) 2004-04-29

Family

ID=25645429

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69813555T Expired - Lifetime DE69813555T2 (de) 1997-05-19 1998-05-19 Gegen die fläche von cryptosporidium-oozysten gerichteten igg1-klasse antikörper

Country Status (6)

Country Link
US (1) US6777222B1 (de)
EP (1) EP0991667B1 (de)
AT (1) ATE237639T1 (de)
DE (1) DE69813555T2 (de)
ES (1) ES2201490T3 (de)
WO (1) WO1998052974A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475747B2 (en) 1997-10-28 2002-11-05 The United States Of America As Represented By The Department Of Health And Human Services Method for detecting Cryptosporidium parvum oocysts
US20070141710A1 (en) * 2005-12-20 2007-06-21 Beckman Coulter, Inc. Stable calibrators for immunoassays
WO2016144933A1 (en) * 2015-03-10 2016-09-15 The Regents Of The University Of California Antibodies to the surface of toxoplasma gondii oocysts and methods of use thereof
CN116143875A (zh) * 2022-07-09 2023-05-23 吉林大学 隐孢子虫cgd2_3080卵囊壁外壁标记蛋白质及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN514695A0 (en) * 1995-08-30 1995-09-21 Australian Water Technologies Pty Ltd Method for detection of cryptosporidium oocysts

Also Published As

Publication number Publication date
WO1998052974A1 (en) 1998-11-26
EP0991667A4 (de) 2000-12-20
ES2201490T3 (es) 2004-03-16
US6777222B1 (en) 2004-08-17
EP0991667B1 (de) 2003-04-16
ATE237639T1 (de) 2003-05-15
EP0991667A1 (de) 2000-04-12
DE69813555T2 (de) 2004-04-29

Similar Documents

Publication Publication Date Title
ZA837603B (en) Immunogenic protein or peptide complex,method of producing said complex and the use thereof as an immune stimulant and as a vaccine
CA2223699A1 (en) In ovo vaccination against coccidiosis
ES2006631A6 (es) Procedimiento para la preparacion de un antigeno peptido inmunogenico correspondiente a la proteina circumsporozoito de plasmodium vivax.
EP1964573A3 (de) Verfahren zur Induzierung und/oder Verbesserung einer Immunreaktion auf Tumorantigene
BR9809656A (pt) Composição imunopotencializante
EP0135712A3 (de) Gegen Sporozoiten von Eimeria Spp. reaktive monoklonale Antikörper und Antigene
DE2967036D1 (en) Vaccine and method of making
JPS5726623A (en) Vaccine and manufacture
EP2058334A3 (de) Monoklonale Antikörper, querschnittsreaktive Antikörper und Verfahren zu ihrer Herstellung
WO1995026982A3 (en) Malaria peptides
DE69813555D1 (de) Gegen die fläche von cryptosporidium-oozysten gerichteten igg1-klasse antikörper
EP0348725A3 (de) Sorten-spezifische Epitode von Chlamydia trachomatis und Antikörper, die diese erkennen
DK0485388T3 (da) Vaccine til immunisering af katte mod udskillelse af toxoplasma-oocyster
EP0839050A4 (de)
JPS6445398A (en) Antithrombin-binding substance monoclonal antibody, hybridoma producing said antibody and method for purifying and measuring thrombin-binding substance utilizing said monoclonal antibody
IL93234A (en) Methods for producing antibodies, antibody probes produced thereby, method for preparing and using antigens utilizing said probes and vaccines prepared therewith
JPS5739350A (en) Preparation of toxoplasma antigen
EP0241139A3 (de) Antiidiotypischer Coccidiaimpfstoff
HK1048323B (zh) 家畜乳房分泌抗體的製作
DE3671603D1 (de) Verfahren zur zucht von babesia canis, verwendung zur herstellung von antigenen und impfstoffen und antigene und impfstoffe gegen piroplasmose.
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
JPS6429400A (en) Monoclonal antibody
DK0476059T3 (da) Fremgangsmåder til forøgelse af modificeringshastigheden for metastabile bindinger
IL97578A0 (en) Plasmodium sporozoite antigen,dna coding therefor,use of said dna for its production and antibodies against it
IT1254147B (it) Metodo di rivelazione di marcatori tumorali.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition